Pulsatileinsulin , sometimes called metabolic activation therapy , or cellular activation therapy describes in a literal sense the intravenous injection of insulin in pulses versus continuous infusions. Injection of insulin in pulses mimics the physiological secretions of insulin by the pancreas into the portal ... action of steady state levels of insulin, while pulsatile hormone secretion may allow recovery of Receptor biochemistry receptor affinity and numbers for insulin. Intermittent intravenous insulin administration with peaks of insulin concentrations may enhance suppression of gluconeogenesis ... at the University of California, Davis , was the pioneer of using pulsatileinsulin in the treatment ..., inadequate insulin delivery, and insulin resistance. PulsatileInsulin and the Liver Normally, insulin is secreted from the pancreas in pulses into the portal vein which brings blood into the liver in variable amounts, closely related to ingestion of meals. For induction and maintenance of insulin ... insulin administration regimens used by diabetic patients a fails to capture the pulsatile nature .... ref cite journal last Grubert first J. M. title Impact of continuous and pulsatileinsulin delivery ... of pulsatile and continuous insulin delivery on insulin action in man. journal Metabolism clinical ... secretions of insulin correspond to the intake of food. The pancreas will secrete variable amounts of insulin based upon the amount of food consumed basically speaking, the more food that is consumed, the more insulin the pancreas will secrete among other factors. The majority of available experimental evidence suggests a more potent hypoglycemic effect of pulsatileinsulin in comparison to continuous insulin infusion. Continuous exposure to insulin and glucagon is known to decrease the hormones ... , and pyruvate kinase , the hepatocytes require a defined insulin level 200 500 U ml ... diabetic subjects, portal insulin concentrations are twofold to threefold greater than those in the peripheral ... more details
Future insulin pumps hope to address this characteristic. See also PulsatileInsulin . Blood content ...About the insulin protein uses of insulin in treating diabetes insulin therapy Distinguish inulin PBB geneid 3630 Insulin is a hormone , produced by the pancreas , which is central to regulating carbohydrate and fat metabolism in the body. Insulin causes cells in the liver , muscle , and fat cell fat tissue to take up glucose from the blood , storing it as glycogen inside these tissues. Insulin stops ... disorder diabetes mellitus and metabolic syndrome , insulin is provided within the body ... of insulin levels fails, diabetes mellitus will result. As a consequence, insulin is used medically ... depend on external insulin most commonly Subcutaneous injection injected subcutaneously for their survival ... 2 type 2 diabetes are often insulin resistance insulin resistant and, because of such resistance, may suffer from a relative insulin deficiency. Some patients with type 2 diabetes may eventually require insulin if other medications fail to control blood glucose levels adequately. Over 40 of those with Type 2 diabetes require insulin as part of their diabetes management plan. Insulin also influences ... . Once insulin enters the human brain, it enhances learning and memory and benefits verbal memory ... C, Hallschmid M, Hatke A, Schultes B, Fehm HL, Born J, Kern W. title Intranasal insulin improves memory ... pmid 15288712 ref Enhancing brain insulin signaling by means of intranasal insulin administration ... that central nervous insulin contributes to the control of whole body energy homeostasis in humans ... H, Schultes B, Born J, Hallschmid M. title Intranasal insulin enhances postprandial thermogenesis and lowers postprandial serum insulin levels in healthy men. journal Diabetes year 2010 pmid 20876713 volume 60 pages 114 118 issue 1 pmc 3012162 unused data Epub ahead of print ref Human insulin ... . Insulin s structure varies slightly between species of animals. Insulin from animal sources ... more details
Pulsatile blood flow in the body is a response to periodic variations in velocity. These pulsating characteristics have been shown to be a result of two pumps. As the primary pump, the heart causes the blood flow and velocity to oscillate from zero to very high rates as the valves at the entrances and exits to the ventricles intermittently close and open with each beat of the heart. The second pump is a result of the respiratory and skeletal systems, which exert their greatest action on venous flow. ref cite book last Trainor first Freida S. title Peripheral Vascular Surgery Hemodynamics of Arterial Pulsatile Blood Flow year 1973 publisher Appleton Century Crofts location New York pages 1 ref Specifically pulsation that result from the release of blood from the left ventricle show that they exhibit non linear, transient pulsations in pressure and flow. These create complex pulse patterns which are further propagated through the rest of the network. This results in variations in the applied shear stress to the layer of enodthelial cells which separate blood flow from the vessel wall. Depending upon the amount of force, the ECs will release chemicals that either induce dilation or constriction of the smooth muscle surrounding the vessel. It is nearly impossible to mathematically model such a flow using the standard Navier Stokes equations . Rather than give an equation that can model the flow, which has proven to be near impossible the Womersley number is used. This dimensionless number has been developed to give a measure of the frequency and magnitude of pulsations rather than a model of the actual flow. Center math alpha R left frac omega nu right 1 2 R left frac omega rho mu right 1 2 , math As you can see, the equation can take on two forms by substituting mu rho for nu . It can also be shown that Wormesley number is primarily influenced by the size of the vessel which can be shown in the table below. Since the density of blood and blood viscosity remain fairly constant ... more details
Image Pancreas insulin oscillations.svg thumb right 250px Insulin release from pancreas is pulsatile with a period of 3 6 minutes. ref name hellman The insulin concentration in blood increases after meals and gradually returns to basal levels during the next 1 2 hours. However, the basal insulin level ... are believed to be important for insulin sensitivity by preventing downregulation of insulin receptor s in target cells. ref name hellman Such downregulation underlies insulin resistance, which is common in type 2 diabetes . It would therefore be advantageous to administer insulin to diabetic patients in a manner mimicking the natural oscillations. ref name hellman The insulin oscillations are generated by pulsatile release of the hormone from the pancreas . Insulin originates from beta ... million islets in the pancreas it is apparent that pulsatile secretion requires sophisticated synchronization both within and among the islets of Langerhans. Image Insulin oscillations.svg thumb right 250px Pulsatileinsulin release from single beta cells is synchronized in each islet of Langerhans as well as among all islets in the pancreas. Mechanism Pulsatileinsulin secretion from ... the cells within the islet. This signal is believed to entrain pulsatileinsulin release from the islets into a common pancreatic rhythm. ref name hellman Clinical significance The insulin oscillations ... and may contribute to insulin resistance. Pulsatileinsulin delivery to the portal vein or islet ... B, Gylfe E, Grapengiesser E, Dansk H, Salehi A title Insulin oscillations clinically important rhythm. Antidiabetics should increase the pulsative component of the insulin release language Swedish ... 6 min . ref name hellman Image Insulin oscillations coordination.svg thumb left 150px Coordination of pulsatileinsulin release. In addition to gap junctions, coordination is done by ATP signaling. Pulsatileinsulin release from the entire pancreas requires that secretion is synchronized between 1 ... more details
There are several methods for transdermal delivery of insulin. Pulsatileinsulin uses microjets ...About uses of insulin in treating diabetes the insulin protein insulin Image Suckale08 fig3 glucose insulin ... hormone insulin blue in humans during the course of a day containing three meals. In addition, the effect of a sucrose sugar rich versus a starch rich meal is highlighted. Insulin therapy is the treatment of diabetes by administration of exogenous insulin . Insulin is used medically to treat ... on external insulin most commonly Injection medicine Subcutaneous injection injected subcutaneously ... mellitus type 2 Type 2 diabetes mellitus are insulin resistance insulin resistant , have relatively low insulin production, or both certain patients with Type 2 diabetes may eventually require insulin ... of Insulin Preparations ref cite web url https secure.pharmacytimes.com lessons 200510 03.asp title Pharmacist s Guide to Insulin Preparations A Comprehensive Review author Takiya, Lisa, Dougherty ... Lysine Thr Threonine Ile Isoleucine Glu Glutamine Gly Glycine Insulin is required for all animal life ... across evolutionary time. Insulin must be administered to patients who experience such a deprivation. Clinically, this condition is called diabetes mellitus type 1 . The initial sources of insulin for clinical use in humans were cow , horse , pig or fish pancreases. Insulin from these sources is effective in humans as it is nearly identical to human insulin three amino acid difference in bovine insulin, one amino acid difference in porcine . Differences in suitability of beef , pork , or fish derived insulin for individual patients have historically been due to lower preparation purity resulting in allergic reactions to the presence of non insulin substances. Though purity has improved steadily ... types of allergic reactions have also been known to occur in response to synthetic human insulin varieties. Insulin production from animal pancreases was widespread for decades, but very few patients ... more details
Image Insulin pen.JPG thumb 400 px Two types of modern, pre filled insulin syringes. An insulin pen is used to inject insulin for the treatment of diabetes . It is composed of an insulin cartridge integrated ... to deliver the dose. Types of pens A number of companies make insulin pens including Novo Nordisk , Aventis ... produce pens for most of their insulins, including Insulin aspart NovoLog NovoRapid , Insulin lispro Humalog , Insulin detemir Levemir and Insulin glargine Lantus . pendiq does not produce insulin and the pendiq pen can work with most of the common insulin cartridges. ref http www.pendiq.com ... pen uses a replaceable insulin cartridge. When the insulin cartridge is empty, the empty cartridge ... comes pre filled with insulin, and when the insulin cartridge or reservoir is empty, the entire unit is discarded. Most brands of insulin are now available for use in pens, these include NovoLog ... Lilly and Company Use Insulin pens are used by 90 to 95 of insulin treated patients in Europe, Asia ... underutilized but growing in use in the United States. Insulin pens offer several significant advantages over insulin syringes ease of handling, accuracy, and more discreet to use. To use ... Insulin pens have a number of advantages More convenient and easier to transport than traditional ... by insertion into a vial of insulin before a second insertion into the skin A memory of 195 injections ... with the traditional syringe , two different insulins cannot be mixed by the user in an insulin pen. ref http www.paralumun.com diabetespen.htm Diabetes Insulin Pen ref On the other hand, some of the newest types of insulin cannot be mixed at all. In addition, using pens and pen needles is usually more expensive than using the traditional vial and syringe method insurance coverage for insulin pens ... group insulinpenusers Insulin Pen Users group http www.diabetes.co.uk insulin diabetes and insulin pens.html Insulin Pen Reviews See also Insulin pump Syringe Standard U 100 insulin syringes Insulin syringe ... more details
Multiple issues primarysources March 2010 unreferenced December 2009 expert March 2010 NPH insulin or neutral ... insulin , is an intermediate acting insulin given to help control the blood sugar level of those with diabetes. NPH was created in 1936 when Novo Nordisk Nordisk formulated isophane porcine insulin by adding neutral protamine to regular insulin. This is a suspension of crystalline zinc insulin ... duration of action, meaning longer than that of regular insulin, and shorter than ultralente , Insulin glargine glargine or Insulin detemir detemir . History Hans Christian Hagedorn 1888 1971 and August Krogh 1874 1949 obtained the rights for insulin from Frederick Banting Banting and Charles ... and B. Norman Jensen discovered that the effects of injected insulin could be prolonged by the addition of protamine obtained from the milt or semen of river trout. The insulin would be added to the protamine ... bok insulin, a mixture of zinc , protamine and porcine insulin. This mixture only needed to be shaken before injection. In 1946, Nordisk was able to form crystals of protamine and insulin and marketed it in 1950 as NPH insulin. NPH insulin has the advantage that it can be mixed with an insulin that has ... on the market today, because manufacturers sell a variety of premixed insulin formulations. However ... injected subcutaneously, and a majority of head to head comparisons with Lente insulin usually found ... replaced by synthetic, Recombinant DNA recombinant human insulin. Synthetic human insulin is also complexed with protamine to form NPH. NPH insulin is cloudy and has an onset of 3 4 hours. Its peak is 4 9 hours and its duration is about 15 hours. Administration NPH insulin may be combined with faster acting insulin to allow more accurate dosing and better blood sugar level control. When administered this way, the two insulin types will normally be combined in the same syringe. NPH and fast acting insulin bind when mixed, so they should not be combined until it is time to inject. Patients are instructed ... more details
refimprove date March 2010 An insulin analog is an altered form of insulin , different from any occurring in nature, but still available to the human body for performing the same action as human insulin ... of insulin can be changed to alter its ADME absorption, distribution, metabolism, and excretion characteristics. Officially, the U.S. Food and Drug Administration FDA refers to these as insulin receptor ligands , although they are more commonly referred to as insulin analogs. These modifications have been used to create two types of insulin analogs those that are more readily absorbed from the injection site and therefore act faster than natural insulin injected subcutaneously, intended to supply the bolus level of insulin needed after a meal and those that are released slowly over a period of between 8 and 24 hours, intended to supply the basal level of insulin for the day. Insulin analog was first manufactured by Eli Lilly and Company . Animal insulin The amino acid sequence for insulin is almost the same in different mammals. Porc ine insulin has only a single amino acid variation from the human variety, and cattle bovine insulin varies by three amino acids. Both are active ... of biosynthetic human insulin, insulin derived from sharks was widely used in Japan. Even insulin ... reactions in a tiny number of people, as can genetically engineered human insulin. This is usually caused by the preservatives used in the insulin rather than the insulin molecule itself. Biosynthetic human insulin has largely replaced animal insulin. With the advent of high pressure liquid chromatography ... a maximum purity level of 97 , which raises questions about the claim of synthetic insulin s purity relative to animal sourced insulin varieties. Chemically and enzymatically modified insulins Before biosynthetic human Recombinant DNA recombinant analogues were available, porcine insulin was chemically converted into human insulin. Chemical modifications of the amino acid side chains at the N ... more details
Drugbox verifiedrevid 476995027 IUPAC name Recombinant human insulin Clinical data tradename pregnancy ... Ref chemspidercite correct chemspider ChemSpiderID NA Chemical data C H N O S Insulin degludec is a ultralong acting basal insulin analogue being developed by Novo Nordisk . It is injected subcutaneously ... acting insulins such as insulin glargine and insulin detemir . ref name dic cite web url http www.diabetesincontrol.com ... weekly insulin&catid 1&Itemid 8 title Good News for Novo s Thrice Weekly Insulin work DiabetesInControl.com ... 2010 06 25 novo s degludec insulin as effective as lantus with fewer doses.html title Novo s Degludec Insulin as Effective as Lantus With Fewer Doses work Bloomberg Businessweek author Schwartzkopff, Frances date 2010 06 25 accessdate 2010 11 07 ref Insulin degludec is a modified insulin that has one single amino acid deleted in comparison to human insulin, and is conjugated to palmitic acid at the amino ... insulin degludec needed to take significantly smaller doses of basal rate basal insulin than those taking insulin glargine, while achieving similar blood glucose levels. Insulin degludec also has the ability ...?cid med&drugid 20805&drugname Insulin Glargine SubQ&monotype monograph&secid 3 title Monograph Insulin Glargine Dosage & Administration work American Society of Health System Pharmacists, Inc ... acting basal with rapid acting mealtime control from insulin aspart . This 2 component insulin ... medscape cite news url http www.medscape.com viewarticle 724316 title Novel Ultralong Acting Insulin as Effective as Insulin Glargine author Lowry, Fran work Medscape accessdate 2010 11 07 ref blockquote Insulin degludec has been filed for registration in the United States. ref name novo cite web url ... the insulin analog in 2013. ref name reuters2 cite news url http www.reuters.com article idUSLDE69Q13H20101027?feedType RSS&feedName rbssHealthcareNews work Reuters title New Novo insulin fails to knock ... drugportal dpdirect.jsp?name Insulin degludec U.S. National Library of Medicine Drug Information ... more details
no footnotes date March 2010 refimprove date March 2010 An insulin port functions as a medication delivery channel directly into the subcutaneous tissue the tissue layer located just beneath the skin . When applying the injection port, an insertion needle guides a soft cannula a small, flexible tube under the skin. Once applied, the insertion needle is removed and only the soft cannula remains below the skin, acting as the gateway into the subcutaneous tissue. To inject through an insulin port the needle of a syringe or insulin pen is used. It is usually used to deliver insulin through the use of an insulin pump . The needle remains above the surface of the skin, while the medication is immediately delivered through the soft cannula and into the subcutaneous tissue. References http spectrum.diabetesjournals.org cgi content abstract 21 3 197 DiabetesJournals.org See also Injection port DEFAULTSORT Insulin Port Category Catheters Category Diabetes related supplies and medical equipment Category Insulin therapies ... more details
More footnotes date March 2010 Image Insulin pump and infusion set.JPG thumb right 300px Insulin pump ... set shown here removed from the pump . Image Insulin pump reservoir.jpg thumb right 300px Filling an insulin pump reservoir. Left to right 1 Reservoir in sterile packaging. 2 Filling the reservoir ... right 300px Image super bolus.JPG thumb right 300px The insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus , also known as continuous Subcutaneous tissue subcutaneous insulin infusion therapy. The device includes the pump itself including controls, processing module, and batteries a disposable reservoir for insulin inside the pump a disposable ... system to interface the insulin reservoir to the cannula. An insulin pump is an alternative to multiple daily injections of insulin by syringe Standard U 100 insulin syringes insulin syringe or an insulin pen and allows for intensive insulin therapy when used in conjunction with blood glucose monitoring and carb counting. Setting up howto date March 2012 To use an insulin pump, the reservoir must first be filled with insulin. Some pumps use prefilled cartridges that are replaced when empty. Most, however, are filled with the insulin prescribed for the user usually Insulin glulisine Apidra , Insulin lispro Humalog , Insulin aspart Novolog or Regular . Setting up includes Opening a new sterile empty pump reservoir Withdrawing the plunger Inserting the needle into a vial of insulin Injecting the air from the reservoir into the vial to prevent a vacuum forming in the vial as insulin is withdrawn Drawing insulin into the reservoir with the plunger, and then removing the needle Squirting out ... set tubing Installing the assembly into the pump and priming the tubing pushing insulin and any ... accidental insulin delivery Attaching to the infusion site and priming the cannula if a new set has been inserted . Dosing An insulin pump allows the replacement of slow acting insulin for basal needs ... more details
noble.html title Insulin Lispro A Fast Acting Insulin Analog accessdate 2007 06 08 work ref Insulin lispro has one primary advantage over regular insulin for postprandial glucose control. It has a shortened delay of onset, allowing slightly more flexibility than regular insulin, which requires ... with a longer acting insulin for good glycemic control. References references External links http ... of Humalog Crystals February 22, 2010 Oral hypoglycemics and insulin analogs DEFAULTSORT Insulin Lispro Category Eli Lilly and Company Category Insulin therapies Category Diabetes Category Human ... Insulinpr parat Insulin lispro nl Insuline lispro pl Insulina lispro sv Insulin lispro ... more details
Drugbox Verifiedfields changed verifiedrevid 464363066 IUPAC name drug name Insulin Detemir Clinical data tradename Drugs.com drugs.com monograph insulin detemir MedlinePlus a606012 pregnancy AU A B1 B2 ... data C 267 H 402 N 64 O 76 S 6 molecular weight 5913 Insulin detemir is a long acting human insulin analogue for maintaining the basal level of insulin. Novo Nordisk markets it under the trade name Levemir . It is an insulin analogue in which a fatty acid myristic acid is bound to the lysine ... Insulin Detemir With NPH Insulin as Add On Therapy to Oral Glucose Lowering Drugs in Insulin Na ve ... , but the proportion achieving this without hypoglycemia was higher with insulin detemir than with NPH insulin 26 vs. 16 , P 0.008 . Compared with NPH insulin, the risk for all hypoglycemia with insulin ... was 1.2 kg with insulin detemir and 2.8 kg with NPH insulin P 0.001 , and the difference in baseline adjusted final weight was 1.58 P 0.001 . In short, it was found that insulin detemir reduced Hemoglobin A1C to target levels of 7.0 for 70 of patients, similar to human basal insulin NPH, but without ... to NPH insulin, the The Levemir package insert states the following disclaimer blockquote LEVEMIR ... represent true differences in the effects of LEVEMIR and NPH insulin is not known, since these trials ... In addition, the safety and efficacy of insulin detemir Levemir in real life clinical practice was evaluated ... insulin after learning that 129,000 stolen vials reappeared and were being sold in the U.S. ..., Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes Rury R. Holman, M.B., Ch.B., F.R.C.P. ... , Insulin analogues insulin detemir and insulin aspart versus traditional human insulins NPH insulin and regular human insulin in basal bolus therapy for patients with Type 1 diabetes, Journal Diabetologia ... www.levemir us.com prescribing information.pdf Levemir Package Insert Oral hypoglycemics and insulin analogs DEFAULTSORT Insulin Detemir Category Insulin therapies de Insulin detemir nl Insuline detemir ... more details
Drugbox Verifiedfields changed verifiedrevid 458271727 IUPAC name Recombinant human insulin Clinical data tradename Drugs.com drugs.com monograph insulin glargine MedlinePlus a600027 pregnancy AU A B1 ... g mol Insulin glargine , marketed by Sanofi Aventis under the name Lantus , is a long acting basal insulin analogue , given once daily to help control the blood sugar level of those with diabetes . It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 ... basal insulin secretion of non diabetic pancreatic beta cells. Sometimes, in type 2 diabetes ... insulin , it can offer moderate control of serum glucose levels. In the absence of endogenous insulin ... latent autoimmune diabetes of adults in late stage Lantus needs the support of fast acting insulin ... of action pharmacodynamics Insulin glargine have substitution of glycine for asparagine at A21 and two ..., resulting in a slow, peakless dissolution and absorption of insulin from the site of injection. ref name Bolli cite journal author Bolli, G. et. al. year 1999 title Insulin analogues and their potential ... , when a physiologic pH approximately 7.4 is achieved the increase in pH causes the insulin to come out of solution resulting in the formation of higher order aggregates of insulin hexamers. The higher order aggregation slows the dissociation of the hexamers into insulin monomers, the functional and physiologically active unit of insulin. This gradual process ensures that small amounts of Lantus ... insulin preparations Unlike some other longer acting insulins, Lantus must not be diluted or mixed with other insulin or solution in the same syringe. ref American Diabetes Association. 2003 . Position statement Insulin administration. Diabetes Care 26 Suppl. 1 , 121 124 ref However, this restriction ... of Texas Childrens Hospital. ref Effects of Mixing Glargine and Short Acting Insulin Analogs ... of Lantus and insulin pen manufacturing at the location Frankfurt H chst lied at 700 Mio. . In 2008 ... more details
Expert subject Medicine date December 2009 Infobox disease Name Insulin resistance Image Caption DiseasesDB ICD10 ICD9 ICDO OMIM MedlinePlus eMedicineSubj med eMedicineTopic 1173 MeshName Insulin Resistance MeshNumber C18.452.394.968.500 Insulin resistance IR is a physiological condition where the natural hormone insulin becomes less effective at lowering blood sugars. The resulting increase in blood ... conditions. Certain cell types such as fat and muscle cell biology cells require insulin to absorb glucose. When these cells fail to respond adequately to circulating insulin, blood glucose levels ... of insulin. This normal reduction in the liver s glucose production may not occur in people with insulin ... www.sciencedaily.com work accessdate ref Insulin resistance in muscle and fat cells reduces glucose ... insulin resistance in liver cells results in reduced glycogen synthesis and storage and a failure to suppress glucose production and release into the blood. Insulin resistance normally refers to reduced glucose lowering effects of insulin. However, other functions of insulin can also be affected. For example, insulin resistance in adipose tissue fat cells reduces the normal effects of insulin on lipids ... plasma . Elevated blood fatty acid concentrations associated with insulin resistance and diabetes ... to elevated blood glucose levels. High plasma levels of insulin and glucose due to insulin resistance are a major component of the metabolic syndrome . If insulin resistance exists, more insulin ... insulin resistance article.htm title www.medicinenet.com work accessdate ref Signs and symptoms Original research section discuss Talk Insulin resistance Original research in symptoms ... may not be found with all people diagnosed with insulin resistance. Fatigue. Brain fogginess ... of insulin resistance. Increased blood triglyceride levels. Increased blood pressure. Many people with hypertension are either diabetic or pre diabetic and have elevated insulin levels due to insulin ... more details
expert date March 2010 Drugbox Verifiedfields changed verifiedrevid 464363109 IUPAC name image Insulin Aspart Structural Formula.gif drug name Insulin Aspart Clinical data tradename Drugs.com drugs.com monograph insulin aspart MedlinePlus a605013 pregnancy AU A B1 B2 B3 C D X pregnancy US C pregnancy ... H 381 N 65 O 79 S 6 molecular weight 5825.8 g mol A fast acting insulin analog marketed by Novo Nordisk as NovoLog NovoRapid is a man made form of human insulin. A single amino acid has been slightly changed in its molecular structure. This change helps the fast acting insulin analog absorb quickly into the bloodstream. As a result, it starts working in minutes, which allows you to take insulin and eat right away. Fast acting insulin analogs are considered to act similar to the way insulin is released ... allows the patient to adjust their insulin according to any changes in their eating habits. ref name ... FAQ accessdate 2011 work ref The safety and efficacy of Insulin aspart NovoLog NovoRapid in real life ... a faster acting insulin. The sequence was inserted into the yeast genome, and the yeast expressed the insulin analogue, which was then harvested from a bioreactor . According to JDRF, insulin ... 2000. cn date February 2011 Chemical properties The components of insulin aspart are as follows Metal ... chloride 0.58 mg mL . The pH of insulin aspart is 7.2 7.6. ref name Pharmaceutical Biotechnology .... However, as with all insulin, these numbers are based on averages, and vary between individuals due ... FDA. NovoLog Insulin Aspart rDNA origin Injection. 7 June 2000. http www.fda.gov CDER foi label 2000 20986lbl.pdf ref Temperature It has been debated whether or not insulin aspart or NovoLog NovoRapid should be refrigerated. Recent studies have shown that there is no difference, however insulin should ... boiling state, and separate. This can change the potency of the insulin, and it would no longer be as effective ... Novolog insulin aspart rDNA origin injection accessdate 2010 10 work ref NovoLog FlexPen , vials and cartridges ... more details
Inhalable insulin was available from September 2006 to October 2007 in the United States as a new method of delivering insulin , a drug used in the treatment of diabetes mellitus diabetes , to the body. After the withdrawal of the only inhalable formulation, all currently available insulin formulations ... cite news author Justin Gillis title Inhaled Form of Insulin Is Approved url http pqasb.pqarchiver.com ... Jan 28 2C 2006&author Justin Gillis&desc Inhaled Form of Insulin Is Approved date January 28, 2006 ... , a powdered form of recombinant human insulin, delivered through an inhaler into the lungs where it is absorbed. Insulin has also been known to help patients with breast cancer, namely women. ref name FDAapproval cite web title FDA Approves First Ever Inhaled Insulin Combination Product for Treatment ... 1 diabetics still need to take a longer acting basal insulin by injection. ref name BBCnews cite news title Diabetes inhaler rejected for NHS Insulin that can be inhaled rather than injected has been ... that inhaled insulin appears to be as effective, but no better than injected short acting insulin ... and cost effectiveness of inhaled insulin in diabetes mellitus a systematic review and economic evaluation ... for daily injections among diabetics. History Insulin was introduced by Banting and Best from the University ... insulin in 1924. ref name washingtonpost Years of failure followed until scientists realized they might be able to use new technologies to turn insulin into a concentrated powder with particles ... insulin can effectively reach the lung capillaries where it is absorbed. ref cite web title Inhalational Insulin Therapy url http insulin news.com inhalable insulin.asp year 2005 publisher Insulin News.com accessdate 2007 10 22 archiveurl http web.archive.org web 20070930084403 http insulin news.com ... testing and formulating inhalable insulin. ref name washingtonpost Once concrete methods were developed ... is a form of inhalable insulin developed by Pfizer . ref name FDAapproval cite web title FDA Approves ... more details
Use dmy dates date July 2011 PBB geneid 3643 The insulin receptor IR is a transmembrane receptor transmembrane receptor proteomics receptor that is activated by insulin , IGF I , IGF II and belongs to the large ... MC title Ligand induced activation of the insulin receptor a multi step process involving structural ... year 2009 month April pmid 19274663 doi 10.1002 bies.200800210 url issn ref Metabolically, the insulin ... . ref name pmid2859121 cite journal author Ebina Y, Ellis L title The human insulin receptor cDNA ... Malaguarnera R, Belfiore A title Proinsulin Binds with High Affinity the Insulin Receptor Isoform ... year 2012 month February pmid 22355074 doi url issn ref Biochemically, the insulin receptor is encoded ... A, Frasca F title Insulin receptor isoforms and insulin receptor insulin like growth factor receptor ... capable of homo or hetero dimerisation to produce the 320 kDa disulfide linked transmembrane insulin ... cleavage site. Image Colour coded Schematic of the Insulin Receptor.png left thumbnail 350px Colour coded schematic of the insulin receptor Upon receptor dimerisation, after Proteolysis protyolytic ... basis for the kinetic differences between the two insulin receptor isoforms. journal Biochemical ... in the insulin receptor and its implications for design of peptide agonists. journal PNAS volume ... CW et al. title Structure of the insulin receptor ectodomain reveals a folded over conformation ... binding The insulin receptors endogenous ligands include insulin , IGF I and IGF II . The binding ... chain. These changes facilitate the recruitment of specific adapter proteins such as the insulin ... L, De Meyts P title Harmonic oscillator model of the insulin and IGF1 receptors allosteric binding ... P, Roth J, Neville DM Jr, Gavin JR 3rd, Lesniak MA title Insulin interactions with its receptors experimental ... ligand Receptor ligand kinetics kinetics insulin IGF I has been identified in the context of the currently ... state that each IR monomer possesses 2 insulin binding sites site 1, which binds to the classical ... more details
The Insulin Index is a measure used to quantify the typical insulin response to various foods. The index ..., the Insulin Index is based upon blood insulin levels. This measure can be more useful than either ... an insulin response despite there being no carbohydrate s present, and some foods cause a disproportionate insulin response relative to their carbohydrate load. Holt et al. have noted that the glucose and insulin scores of most foods are highly correlated, ref name Cure for Diabetes http books.google.it books?id 2aTatu9P XwC&pg PT144&dq insulin index&hl it&ei DBdZTYGSCMLIswblqOWLAg&sa X&oi book result&ct result&resnum 1&ved 0CCkQ6AEwAA v onepage&q insulin 20index&f false There Is a Cure for Diabetes ... carbohydrates elicit insulin responses that were disproportionately higher than their glycemic responses. They also conclude that insulin indices may be useful for dietary management and avoidance of non insulin dependent diabetes mellitus and hyperlipidemia. Explanation of Index The insulin index shows how much insulin is present in people s blood as a result of a particular food, the glucose ... and insulin scores were determined by feeding 1000 kilojoules 239 kilocalories of the food to the participants and recording the area under the glucose insulin curve for 120 minutes then dividing by the area under the glucose insulin curve for white bread. The result being that all scores are relative ... date 1996.11.21 title An insulin index of foods the insulin demand generated by 1000 kJ portions of common ... 2011 06 02 laysummary http www.mendosa.com insulin index.htm laysource Insulin Index By David Mendosa laydate 2009.10.14 ref insulin ref name Holt1997 and satiety scores ref Cite journal last1 ... laydate 2005.01.10 year 1995 ref Food Food Type Glucose score Insulin score Satiety score All ... Food Food Type Glucose score Insulin score Satiety score Reflist group n See also Glycemic index Glycemic load Insulin oscillations References Reflist M kel inen, H, The effect of glucan on the glycemic ... more details
orphan date February 2009 Oralin is a premeal oral insulin currently under investigation. The medicine is administered as an oral spray. It is currently evaluated in comparison with oral hypoglycemic agent s, mostly in patients with type 2 diabetes type 2 Diabetes mellitus DM . The clinical data appears promising, but further evaluation of its efficacy in type 1 diabetes type 1 DM is needed. ref cite book title Nelson Textbook of Pediatrics by Robert M Kliegman, Richard E Behrman, Hal B Jenson, Bonita F Stanton ref References reflist 3 External links Category Pharmacology Oralin gastrointestinal drug stub ... more details
Z is a regulatory sequence for the insulin gene ref Melloul et al., Diabetologica, 45, 309 326, year 2002. Regulation of insulin gene transcription ref References reflist Insulin gene regulatory sequences Category Regulatory sequences biochemistry stub ... more details
A2 is a regulatory sequence for the insulin gene ref Melloul et al., Diabetologica, 45, 309 326, year 2002. Regulation of insulin gene transcription ref References reflist Insulin gene regulatory sequences Category Regulatory sequences biochemistry stub ... more details
A5 is a regulatory sequence for the insulin gene ref Melloul et al., Diabetologica, 45, 309 326, year 2002. Regulation of insulin gene transcription ref References reflist Insulin gene regulatory sequences Category Regulatory sequences biochemistry stub es Caja A5 ... more details
A3 is a regulatory sequence for the insulin gene ref Melloul et al., Diabetologica, 45, 309 326, year 2002. Regulation of insulin gene transcription ref References reflist Insulin gene regulatory sequences Category Regulatory sequences biochemistry stub es Caja A3 ... more details
Encyclopedia
top
